Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Bristol ...

<< Previous

Bullboard Posts

Next >>

Comment by StockingUp21on Jun 04, 2022 9:12am

87 Views

Post# 34731527

RE:RE:RE:Bristol ...

again projection. You are proveto have more alias. I am not studders or anyone.

it's not right to talk about a reputabl pharma in the same sentence as this one until they are proven. False equivalence.

MrMugsy wrote:

StockingUp21 wrote:
False equivalence is a logical fallacy in which an equivalence is drawn between two subjects based on flawed or false reasoning. This fallacy is categorized as a fallacy of inconsistency. Colloquially, a false equivalence is often called "comparing apples and oranges."

Let me draw equivalence for you ...

stockings = stutters

Are you taking the bet or are you too scared ?

: )